CymaBay Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CymaBay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • CymaBay Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$42.5M, a 81% decline year-over-year.
  • CymaBay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$102M, a 9.2% decline year-over-year.
  • CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$102M, a 9.2% decline from 2022.
  • CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$93.1M, a 6.31% decline from 2021.
  • CymaBay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$87.6M, a 66.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$102M -$8.57M -9.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$93.1M -$5.53M -6.31% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$87.6M -$35M -66.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$52.6M +$55.5M +51.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$108M -$35.6M -49.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$72.5M -$51.2M -240% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$21.3M +$4.26M +16.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$25.6M +$311K +1.2% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 -$25.9M -$1.89M -7.87% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-23
2014 -$24M -$14.6M -156% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 -$9.4M +$1.04M +9.98% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-23
2012 -$10.4M Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.